Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fewer drops, same relief? trial tests Twice-Daily systane complete against standard Four-Times-Daily regimen

NCT ID NCT07722650

Completed Symptom relief Sponsor: Instituto Internacional de Medicina y Terapia (IIMET) Source: ClinicalTrials.gov ↗

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial investigates whether using Systane Complete eye drops twice a day works as well as using Thealoz Duo eye drops four times a day for adults with mild to moderate dry eye disease. Over 30 days, participants will use one of the two regimens and report symptom changes through a questionnaire, while doctors measure tear film stability and eye surface health. The goal is to see if a simpler dosing schedule can provide comparable symptom relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
lipid-containing artificial tears (Systane Complete) compared to another artificial tear (Thealoz Duo)
What this could lead to
If successful, this could offer a simpler, less frequent dosing option for managing dry eye symptoms.
What could go wrong
This is a small, short-term trial comparing two existing products, so any advantage may be modest or not apply to all dry eye patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE SYNDROME (DES) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE SYNDROME (DES) OCULAR SURFACE DISEASE

Contacts and locations

Locations

  • Hospital Puerta de Hierro

    Zapopan, Jalisco, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.